Keywords: axcan, says, photofrin, excellent, new, use, pharma

Axcan says Photofrin "excellent" in new use

Article | 01 July 2002

Print This

Axcan Pharma of Quebec has said that a Phase III trial of itsphotodynamic therapy for high grade dysplasia associated with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in